+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

NGS-Based RNA-Sequencing Market Research Report by Product & Service, Technology, Application, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 134 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5533386
UP TO OFF until Dec 31st 2022
The United States NGS-Based RNA-Sequencing Market size was estimated at USD 231.41 million in 2021, USD 274.75 million in 2022, and is projected to grow at a CAGR 20.90% to reach USD 722.74 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the NGS-Based RNA-Sequencing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market was studied across Data Analysis, Storage & Management, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, and Sample Preparation Products. The Sample Preparation Products is further studied across Library Preparation & Target Enrichment, Quality Control, Sample Preparation Products, By Method, and Sample Preparation Products, By Workflow. The Sample Preparation Products, By Method is further studied across Manual Sample Preparation, Microfluidic Sample Preparation, and Robotic Liquid Handling Sample Preparation.
  • Based on Technology, the market was studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-molecule Real-time Sequencing.
  • Based on Application, the market was studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics.
  • Based on End User, the market was studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for NGS-Based RNA-Sequencing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the NGS-Based RNA-Sequencing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States NGS-Based RNA-Sequencing Market, including Agilent Technologies, Bgi Group, Eurofins Scientific, F. Hoffmann-la Roche Ag, Genewiz, Hamilton Company, Illumina, Nugen Technologies, Oxford Nanopore Technologies, Perkinelmer, Psomagen, Qiagen, Takara Bio, Thermo Fisher Scientific, and Zymo Research.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States NGS-Based RNA-Sequencing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States NGS-Based RNA-Sequencing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States NGS-Based RNA-Sequencing Market?
4. What is the competitive strategic window for opportunities in the United States NGS-Based RNA-Sequencing Market?
5. What are the technology trends and regulatory frameworks in the United States NGS-Based RNA-Sequencing Market?
6. What is the market share of the leading vendors in the United States NGS-Based RNA-Sequencing Market?
7. What modes and strategic moves are considered suitable for entering the United States NGS-Based RNA-Sequencing Market?
Frequently Asked Questions about the U.S. NGS-Based RNA-Sequencing Market

What is the estimated value of the U.S. NGS-Based RNA-Sequencing Market?

The U.S. NGS-Based RNA-Sequencing Market was estimated to be valued at $231.41 Million in 2021.

What is the growth rate of the U.S. NGS-Based RNA-Sequencing Market?

The growth rate of the U.S. NGS-Based RNA-Sequencing Market is 20.9%, with an estimated value of $722.74 Million by 2027.

What is the forecasted size of the U.S. NGS-Based RNA-Sequencing Market?

The U.S. NGS-Based RNA-Sequencing Market is estimated to be worth $722.74 Million by 2027.

Who are the key companies in the U.S. NGS-Based RNA-Sequencing Market?

Key companies in the U.S. NGS-Based RNA-Sequencing Market include Agilent Technologies, Bgi Group, Eurofins Scientific, F. Hoffmann, la Roche Ag, Genewiz, Hamilton Company, Illumina and Oxford Nanopore Technologies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Ngs-Based Rna-Sequencing Market, by Product & Service
6.1. Introduction
6.2. Data Analysis, Storage & Management
6.3. Rna Sequencing Platforms & Consumables
6.4. Rna Sequencing Services
6.5. Sample Preparation Products
6.5.1. Library Preparation & Target Enrichment
6.5.2. Quality Control
6.5.3. Sample Preparation Products, by Method
6.5.3.1. Manual Sample Preparation
6.5.3.2. Microfluidic Sample Preparation
6.5.3.3. Robotic Liquid Handling Sample Preparation
6.5.4. Sample Preparation Products, by Workflow
7. Ngs-Based Rna-Sequencing Market, by Technology
7.1. Introduction
7.2. Ion Semiconductor Sequencing
7.3. Nanopore Sequencing
7.4. Sequencing by Synthesis
7.5. Single-Molecule Real-Time Sequencing
8. Ngs-Based Rna-Sequencing Market, by Application
8.1. Introduction
8.2. De Novo Transcriptome Assembly
8.3. Expression Profiling Analysis
8.4. Small Rna Sequencing
8.5. Variant Calling & Transcriptome Epigenetics
9. Ngs-Based Rna-Sequencing Market, by End-user
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Pharmaceutical & Biotechnology Companies
9.4. Research & Academia
10. California Ngs-Based Rna-Sequencing Market11. Florida Ngs-Based Rna-Sequencing Market12. Illinois Ngs-Based Rna-Sequencing Market13. New York Ngs-Based Rna-Sequencing Market14. Ohio Ngs-Based Rna-Sequencing Market15. Pennsylvania Ngs-Based Rna-Sequencing Market16. Texas Ngs-Based Rna-Sequencing Market
17. Competitive Landscape
17.1. Fpnv Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, by Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Agilent Technologies
18.2. Bgi Group
18.3. Eurofins Scientific
18.4. F. Hoffmann-La Roche Ag
18.5. Genewiz
18.6. Hamilton Company
18.7. Illumina
18.8. Nugen Technologies
18.9. Oxford Nanopore Technologies
18.10. Perkinelmer
18.11. Psomagen
18.12. Qiagen
18.13. Takara Bio
18.14. Thermo Fisher Scientific
18.15. Zymo Research
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
FIGURE 8. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2027
FIGURE 11. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, STORAGE & MANAGEMENT, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, STORAGE & MANAGEMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION & TARGET ENRICHMENT, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION & TARGET ENRICHMENT, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY QUALITY CONTROL, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY QUALITY CONTROL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY METHOD, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY METHOD, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MANUAL SAMPLE PREPARATION, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MANUAL SAMPLE PREPARATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MICROFLUIDIC SAMPLE PREPARATION, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MICROFLUIDIC SAMPLE PREPARATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ROBOTIC LIQUID HANDLING SAMPLE PREPARATION, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ROBOTIC LIQUID HANDLING SAMPLE PREPARATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY WORKFLOW, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY WORKFLOW, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 34. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 36. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2027
FIGURE 47. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 56. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 57. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2027
FIGURE 58. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 60. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 (USD MILLION)
FIGURE 61. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, 2019-2027 (USD MILLION)
FIGURE 63. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 64. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 72. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 73. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NGS-BASED RNA-SEQUENCING MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, STORAGE & MANAGEMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY LIBRARY PREPARATION & TARGET ENRICHMENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY QUALITY CONTROL, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY METHOD, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MANUAL SAMPLE PREPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY MICROFLUIDIC SAMPLE PREPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ROBOTIC LIQUID HANDLING SAMPLE PREPARATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY WORKFLOW, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 33. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 34. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 35. CALIFORNIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 38. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 39. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 40. FLORIDA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 41. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 43. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 44. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 45. ILLINOIS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 46. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 48. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 49. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 50. NEW YORK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 51. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 53. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 54. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 55. OHIO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 57. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 60. PENNSYLVANIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 61. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2019-2027 (USD MILLION)
TABLE 63. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 64. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 65. TEXAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 67. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 68. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 69. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET RANKING
TABLE 70. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 71. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET MERGER & ACQUISITION
TABLE 72. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 73. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 74. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET INVESTMENT & FUNDING
TABLE 75. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 76. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET: LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies
  • Bgi Group
  • Eurofins Scientific
  • F. Hoffmann-la Roche Ag
  • Genewiz
  • Hamilton Company
  • Illumina
  • Nugen Technologies
  • Oxford Nanopore Technologies
  • Perkinelmer
  • Psomagen
  • Qiagen
  • Takara Bio
  • Thermo Fisher Scientific
  • Zymo Research

Methodology

Loading
LOADING...